Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Eur J Heart Fail ; 14(8): 895-901, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22588321

RESUMO

AIMS: Persistence of left ventricular (LV) systolic dysfunction after 6 months of diagnosis is believed to be a marker of an irreversible cardiomyopathy in peripartum cardiomyopathy (PPCM). We sought to determine the length of time required for recovery of LV systolic function (LVSF) in patients with PPCM. METHODS AND RESULTS: Forty-two consecutive women with PPCM were enrolled in this prospective study. The minimum required time of follow-up for inclusion was 30 months. Each patient underwent transthoracic echocardiography, and plasma brain natriuretic peptide (BNP) and C-reactive protein measurement at admission, and every 3 months. Early recovery was defined as normalization of LVSF at 6 months post-diagnosis. Delayed recovery was defined if the length of time required for recovery of LVSF was longer than 6 months. Persistent left ventricular dysfunction (PLVD) was defined as an ejection fraction of <50% at the end of follow-up. Twenty patients (47.6%) recovered completely, 10 died (23.8%), and 12 (28.6%) had PLVD. Average time to complete recovery was 19.3 months after initial diagnosis (3-42 months). Early recovery was observed only in six patients (30%), whereas delayed recovery was observed in 14 out of 20 patients (70%). Patients with complete recovery were more likely to have a higher LV ejection fraction and smaller LV end-systolic dimensions at baseline. CONCLUSION: Full recovery of LVSF in PPCM patients often requires longer than 6 months.


Assuntos
Cardiomiopatias/etiologia , Complicações Cardiovasculares na Gravidez/etiologia , Disfunção Ventricular Esquerda/complicações , Adolescente , Adulto , Análise de Variância , Biomarcadores , Proteína C-Reativa , Cardiomiopatias/diagnóstico por imagem , Cardiomiopatias/patologia , Feminino , Humanos , Peptídeo Natriurético Encefálico , Gravidez , Complicações Cardiovasculares na Gravidez/diagnóstico por imagem , Complicações Cardiovasculares na Gravidez/patologia , Estudos Prospectivos , Fatores de Risco , Volume Sistólico , Fatores de Tempo , Ultrassonografia , Disfunção Ventricular Esquerda/diagnóstico por imagem , Disfunção Ventricular Esquerda/patologia , Função Ventricular Esquerda , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA